[CLDX] QoQ Quarter Result on 30-Jun-2011 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
04-Aug-2011
Financial Year
2011
Quarter
30-Jun-2011 [#Q2]
Profit Trend
QoQ- -1.76%
YoY- -7.46%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Revenue 2,433 2,434 2,363 1,952 2,516 37,721 2,408 0.69%
PBT -13,083 -12,294 -11,334 -9,802 -9,574 23,046 -8,755 30.67%
Tax -410 268 -288 -158 -268 1,449 -248 39.77%
NP -13,516 -12,732 -11,772 -10,236 -10,059 22,661 -9,087 30.27%
Tax Rate - - - - - -6.29% - -
Total Cost 15,949 15,166 14,135 12,188 12,575 15,060 11,495 24.37%
Ratio Analysis
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
NP Margin -555.53 -523.09 -498.18 -524.39 -399.80 60.08 -377.37 29.37%
Per Share
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
EPS -4.04 -3.81 -4.00 -4.10 -4.71 10.61 -4.27 -3.62%
EPS Diluted -4.04 -3.81 -4.00 -4.10 -4.71 10.61 -4.27 -3.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.